| | ATEZOLIZUMAB UNDER REAL-WORLD CONDITIONS IN PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE |
Pending |
30 Jul 2020 |
| | Avigan Trial |
Ongoing |
11 Sep 2020 |
| | B-Clear Study |
Ongoing |
24 Sep 2020 |
| | CAIN457A2318: A randomized, double-blind, placebo controlled, multicenter study of subcutaneous secukinumab, to demonstrate efficacy after twelve weeks of treatment and to assess safety, tolerability . . . |
Completed |
04 Jun 2020 |
| | Convalescent Plasma Therapy as Adjunctive Therapy for Hospitalized Patients with COVID-19: Co-CLARITY Trial . . . |
Pending |
24 Aug 2020 |
| | Copanlisib and rituximab in relapsed indolent B-cell non-Hodgkin’s lymphoma (iNHL) |
Ongoing |
13 Sep 2018 |
| | Copanlisib and rituximab in relapsed indolent B-cell non-Hodgkin’s lymphoma (iNHL) |
Ongoing |
13 Sep 2018 |
| | Debio 1347-201 – Phase II basket trial in solid tumors harboring a fusion of FGFR1-3 |
Terminated |
15 Oct 2020 |
| | Dexamethasone Posterior Segment Drug Delivery System Versus Laser Photocoagulation in Patients with Diabetic Macular Edema (Ozurdex DME Study 206207-026) . . . |
Completed |
24 Feb 2020 |
| | Double-blind, Randomized, Multicenter, Phase III Clinical Study to Compare the Efficacy and to Evaluate the Safety and Immunogenicity of Trastuzumab Biosimilar HLX02 and EU-sourced Herceptin® in Prev . . . |
Ongoing |
07 Oct 2019 |
| | Effects of Brown Rice Consumption on the Metabolic Risk Factors of Non–Communicable Diseases in Selected Filipino Adults: A Randomized Controlled Study . . . |
Completed |
25 Jul 2019 |
| | Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus . . . |
Ongoing |
21 Sep 2020 |
| | Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to less than 4 Years of Age with Partial-onset Seizures . . . |
Ongoing |
28 Jun 2019 |
| | Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001) . . . |
Ongoing |
21 Apr 2021 |
| | Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) . . . |
Ongoing |
21 Apr 2021 |
| | Efficacy and Safety of Vitex negundo for MILD COVID-19 Trial (EVICT Program) |
Ongoing |
26 Jan 2021 |
| | Efficacy of a Filipino asthma action plan in the management of children aged 6 to 18 with partly controlled or uncontrolled asthma: A randomized controlled trial . . . |
Completed |
13 Nov 2019 |
| | EffisayilTM 2: Multi-center, randomized, parallel group, double blind, placebo controlled, Phase IIb dose-finding study to evaluate efficacy and safety of BI 655130 (Spesolimab) compared to placebo in . . . |
Ongoing |
20 Apr 2021 |
| | Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK8835/PF-04971729) (MK-8835-059) |
Ongoing |
14 Sep 2020 |
| | Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants . . . |
Pending |
23 Jul 2020 |
| | Evaluation of the immunogenicity and safety of Japanese encephalitis vaccine when given with measles-mumps-rubella vaccine . . . |
Completed |
20 Jun 2019 |
| | FALCON Study |
Ongoing |
11 Oct 2019 |
| | Gastrointestinal and genitourinary toxicities in two different dose fractionation regimens of high dose rate intracavitary brachytherapy (7Gy x 4 fractions vs 8Gy x 3 fractions) for carcinoma of the u . . . |
Suspended |
27 Jul 2020 |
| | GenVivo / EPB-002 |
Ongoing |
12 Mar 2021 |
| | High dose MelAtonin in symptomatic, hypoxemic Covid-19 Patients Requiring hOspitalization (MAC19 PRO): A Randomized, Double-Blind, Placebo Controlled Trial . . . |
Ongoing |
30 Nov -0001 |